Dopar
FDA Approves Dotarem, a New MRI Agent »
"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
Dopar
Please Note: This Brand Name drug is no longer available in the US.(Generic versions may still be available.)
| In order to reduce the high incidence of adverse reactions, it is necessary to individualize the therapy and to gradually increase the dosage to the desired therapeutic level. |
DRUG DESCRIPTION
Larodopa is available as tablets containing 0.1 g, 0.25 g or 0.5 g levodopa. Each tablet also contains corn starch, magnesium stearate, microcrystalline cellulose, povidone, talc and D&C Red No.7 lake dye.
Chemically, levodopa is (-)-3-(3,4-dihydroxy-phenyl)-L-alanine. It is a colorless, crystalline compound, slightly soluble in water and insoluble in alcohol, with a molecular weight of 197.2.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Dopar Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
